Endo Settles New York Opioid Trial For $50M Before Judge’s Sanctions Ruling

Mealey's (September 10, 2021, 10:19 AM EDT) -- Drug manufacturer Endo International PLC and related subsidiaries on Sept. 9 announced that they have settled an ongoing opioid trial in New York state court for $50 million, the agreement coming...
To view the full article, register now.